Akèy › Degeneresans makile › Oregon › Eugene

Etid klinik pou Degeneresans makile nan Eugene, OR

5 etid pou Degeneresans makile ap chèche patisipan nan sit nan ak bò kote Eugene (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Ap rekriteFaz 2/3

Verum Research LLC, Eugene
Cascade Medical Research Institute, LLC, Springfield · 3 mi lwen

Laj 60 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06635148

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Ap rekriteFaz 3

Verum Research LLC, Eugene
Cascade Medical Research Institute LLC, Springfield · 3 mi lwen

Laj 50 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT06541704

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Ap rekriteFaz 1/2

Verum Research, LLC, Eugene

Laj 50 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT05197270

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

Ap rekriteFaz 2/3

Cascade Medical Research Institute, LLC, Springfield · 3 mi lwen

Laj 50 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07496567

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Ap rekriteFaz 3

Verum Research, LLC, Eugene

Laj 50 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT07064759

Etid Degeneresans makile nan lòt vil

Lòt etid nan Eugene

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.